http://www.prnewswire.com/news-releases/romark-laboratories-awarded-contract-for-late-stage-development-of-new-influenza-drug-193900621.html
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment